Filter
81
Filtered Results: 81
Text search:
GAELF
Featured
Recommendations
8
New Publications
1
Language
Document type
No document type
28
Studies & Reports
24
Guidelines
10
Manuals
8
Strategic & Response Plan
4
Fact sheets
3
Videos
2
Training Material
1
Infographics
1
Countries / Regions
Global
10
Senegal
3
Africa
3
Germany
3
Western and Central Europe
3
Kenya
2
Ghana
2
Cameroon
2
Latin America and the Carribbean
2
West and Central Africa
2
East and Southern Africa
2
India
2
Lesotho
1
Sierra Leone
1
Rwanda
1
Malawi
1
Zimbabwe
1
Haiti
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Bangladesh
1
South Africa
1
Ethiopia
1
Ecuador
1
Myanmar / Burma
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Studies & Reports
6
COVID-19
5
Guidelines
5
Lymphaticfilariasis
3
Drugs & Medical Equipment
3
Helminthiasis
2
Capacity Building
2
General Guidelines
2
Schistosomiasis
1
Dermatology
1
Cancer
1
Palliative Care
1
Cancer Treatment & Resources
1
Vaccine-preventable Diseases
1
Countries
1
NCD
1
Demograhic Health Surveys DHS
1
Policies
1
Disabilities
1
Mental Health
1
Other
1
Surgery & Anaesthesia
1
NTDs & Others
1
Neonatal Care
1
Disease Prevention & Control
1
Physiotherapy & Rehabilitation
1
Toolboxes
Prevention & Control
8
Studies & Reports
6
Country specific documents
3
Capacity Building & Resources
3
Clinical Aspects & Diagnostics
3
Information & Education Material (IEC)
3
Training Supporting Material mhGAP
2
Communication Material
2
Statistics & Facts
2
General Information
2
Neurological Disorders
2
Tuberculosis
2
Mental Health GAP Action Programme
2
Advocacy
1
Clinical Guidelines
1
Hygiene
1
Children & Adolescents
1
International
1
Interculturality
1
Wheelchair Service and Management
1
Drug resistance
1
Africa
1
Others
1
Health Equity & Equality
1
Women's Mental Health
1
Epilepsy
1
Laboratory
1
Context & Facts, Travel Advice
1
Diagnostics & Laboratory Guidance
1
Covid-19 & the One Health Approach
1
COVID-19
1
Training, others
1
Faith-based Organizations
1
Clinical Guidelines
1
Country Specific
1
Global Impact: Socio-economic, health services, TB & HIV
1
Principles of Solidarity
1
Sustainability
1
Community Health
1
Fair Allocation & Ethical Aspects
1
Others
1
Community Health Workers CHW
1
Wound management
1
Pediatrics
1
General documents One Health
1
Epilepsy
1
Information Refugees Ukraine
1
Prevention & Measures
1
Ethics
1
General
1
Strategies & Roadmaps
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Onchocerciasis
1
Education
1
Official Development Assistance
1
General Information & Methodology
1
Assistive devices & technologies
1
TB & Prisoners
1
Situation Reports & Updates
1
Overview & Statistics
1
TB
1
Lobby and Advocacy
1
HIV in Key Populations
1
Global Health Financing
1
Depression
1
Universal Health Coverage & Primary Health Care
1
Neurological disorders, Others
1
N Engl J Med 2014; 371:2083-2091November 27, 2014DOI: 10.1056/NEJMoa1411099
Free Download from the website http://www.nejm.org/doi/full/10.1056/NEJMoa1411099?query=TOC
Global spending on health: Weathering the storm
recommended
The 2020 Report analyzes global health spending for 190 countries from 2000 to 2018 and provides insights as to the health spending trajectory from the MDG era to the SDG era prior to the crisis of 2020. The report shows that global spending on health continually rose between 2000 and 2018 and reach...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t...
The unparalleled action needed to combat unprecedented inequality in the wake of COVID-19.
New billionaire minted every 26 hours, as inequality contributes to the death of one person every four seconds
Available in English, French, Spanish and Arabic https://www.oxfam.org/en/research/inequality-ki...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
Lymphatic filariasis (LF) is a preventable neglected tropical disease (NTD) caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi or B. timori. Mosquitos in the genera Culex, Anopheles, Mansonia and Aedes transmit the parasites from person to person. Lymphoedema and hyd...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
We are pleased to provide an editorial to introduce this series of articles on the achievements of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) over the last 2 decades. We
are delighted that so many of the major players in this journey have agreed to contribute to this supplement,...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
Film / Video
Film / Video
Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease. Infection
occurs when filarial parasites are transmitted to humans through mosquitoes. When a mosquito
with infective stage larvae bites a person, the parasites are deposited on the person’s skin from
where ...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co...
La filariose lymphatique (FL) est une maladie évitable, incapacitante et défigurante, due à une infestation par des filaires parasites des espèces Wuchereria bancrofti, Brugia malayi et B. timori. On estime que 51,4 millions de personnes sont infectées dans le monde. Le lymphœdème et l’hydr...
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...
Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease. Infection occurs when filarial parasites are transmitted to humans through mosquitoes. When a mosquito with infective stage larvae bites a person, the parasites are deposited on the person’s skin from where the...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health and quality of life of people affected and their...
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i...
